Catheter Ablation of Atrial Fibrillation in Adult Congenital Heart Disease: Procedural Characteristics and Outcomes
Authors:
- Tiffany Y. HuTHTiffany Y. Hu
- Chaitra JangaCJChaitra Janga
- Nicholas Y. TanNicholas Y. Tan
- David O. HodgeDHDavid O. Hodge
- Ramila A. MehtaRMRamila A. Mehta
- Christopher J. McLeodCMChristopher J. McLeod
- Anca ChiriacACAnca Chiriac
- William R. MirandaWMWilliam R. Miranda
- Heidi M. ConnollyHCHeidi M. Connolly
- Samuel J. AsirvathamSASamuel J. Asirvatham
- Abhishek J. DeshmukhADAbhishek J. Deshmukh
- 1 August 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 16 (8) , 437-446
Abstract
BACKGROUND: The outcomes of catheter ablation for atrial fibrillation in adults with congenital heart disease are not well described. METHODS: In a retrospective study of adult patients with congenital heart disease who underwent catheter ablation for atrial fibrillation between 2000 and 2020 at Mayo Clinic, procedural characteristics and outcomes were collected. The primary outcomes were atrial arrhythmia (AA) recurrence following a 3-month blanking period and repeat ablation. An arrhythmia clinical severity score was assessed pre- and post-ablation based on the duration of arrhythmia episodes, symptoms, cardioversion frequency, and antiarrhythmic drug use. RESULTS: One hundred forty-five patients (age, 57±12 years; 28% female; 63% paroxysmal atrial fibrillation) underwent 198 ablations with a median follow-up of 26 months (interquartile range, 14–69). One hundred ten, 26, and 9 patients had simple, moderate, and complex congenital heart disease, respectively. All patients underwent pulmonary vein isolation, and non–pulmonary vein targets were ablated in 79 (54%). AA recurrence at 12 months was 37% (95% CI, 29%–45%). On univariate analysis, increasing left atrial volume index was associated with higher odds of AA recurrence (odds ratio, 1.03 [1.00–1.06] per 1 mL/m 2 increment; P =0.05). Noninducibility of atrial flutter was predictive of decreased odds of AA recurrence (odds ratio, 0.43 [0.21–0.90]; P =0.03). A second ablation was performed in 43 patients after a median of 20 (interquartile range, 8–37) months. Arrhythmia clinical severity scores improved following ablation, reflecting a decrease in symptoms, cardioversions, and antiarrhythmic drugs. CONCLUSIONS: Catheter ablation of atrial fibrillation is feasible and effective in patients with adult congenital heart disease and reduces symptoms. Recurrence of AA frequently requires repeat ablation.Keywords
This publication has 22 references indexed in Scilit:
- Time Course of Atrial Fibrillation in Patients With Congenital Heart DefectsCirculation: Arrhythmia and Electrophysiology, 2015
- Lifetime Prevalence of Congenital Heart Disease in the General Population From 2000 to 2010Circulation, 2014
- Pulmonary Vein Isolation for the Treatment of Drug-Refractory Atrial Fibrillation in Adults with Congenital Heart DiseaseCongenital Heart Disease, 2012
- Transseptal access and atrial fibrillation ablation guided by intracardiac echocardiography in patients with atrial septal closure devicesHeart Rhythm, 2011
- Outcome of Intra-Atrial Re-Entrant Tachycardia Catheter Ablation in Adults With Congenital Heart DiseaseJACC, 2010
- The emerging burden of hospital admissions of adults with congenital heart diseaseHeart, 2010
- Atrial Arrhythmias in Adults With Congenital Heart DiseaseCirculation, 2009
- Prophylactic cavotricuspid isthmus block during atrial fibrillation ablation in patients without atrial flutter: a randomised controlled trialHeart, 2009
- Randomized Study Comparing Combined Pulmonary Vein–Left Atrial Junction Disconnection and Cavotricuspid Isthmus Ablation Versus Pulmonary Vein–Left Atrial Junction Disconnection Alone in Patients Presenting With Typical Atrial Flutter and Atrial FibrillationCirculation, 2003
- Influence of patient factors and ablative technologies on outcomes of radiofrequency ablation of intra-atrial re-entrant tachycardia in patients with congenital heart diseaseJACC, 2002